LIVZON PHARMAC. GRP H YC1 (LP6) — Cash Flow Quality Index
LIVZON PHARMAC. GRP H YC1 (LP6) has a Cash Flow Quality Index of 1.55x as of December 2025. Operating cash flow of €3.15 Billion exceeds net income of €2.02 Billion, indicating high earnings quality where cash backs reported profits. Also explore LP6 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LIVZON PHARMAC. GRP H YC1 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for LIVZON PHARMAC. GRP H YC1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LIVZON PHARMAC. GRP H YC1 tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for LIVZON PHARMAC. GRP H YC1 (2021–2025)
Year-by-year earnings quality comparison for LIVZON PHARMAC. GRP H YC1. For live market cap and the full company financial profile, see LIVZON PHARMAC. GRP H YC1 stock valuation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.55x | €3.15 Billion | €2.02 Billion | ▲ +7.6% |
| 2024 | 1.45x | €2.98 Billion | €2.06 Billion | ▼ -13.1% |
| 2023 | 1.66x | €3.25 Billion | €1.95 Billion | ▲ +14.5% |
| 2022 | 1.45x | €2.77 Billion | €1.91 Billion | ▲ +35.5% |
| 2021 | 1.07x | €1.90 Billion | €1.78 Billion | — |